NEOS Surgery — Unstaged equity · €1M partial: only one investor's ticket was disclosed

NEOS Surgery announced a €5M operation that brought Avançsa (the Catalan government's investment company) and Jiadel Medical into its shareholding; the amount recorded is the 2020 equity, Avançsa's €1M. The €5M combines Jiadel Medical's co-investment and commercial agreement from early 2018, Avançsa's 2020 capital increase (approved by the Catalan government on 17 March 2020 through Acord GOV/47/2020, under the Innova Global line) and a €1M loan tied to the investment. This is the same deal as the '€1M, 2020-03-18' entry already on record, which is the date of Avançsa's approval. The funds were for clinical validation of DISC care and CE and international certification. Separately, NEOS won a €1.9M non-refundable EIC Accelerator grant for DISC care, which is not a funding round. The Catalan government later authorised Avançsa to put another €1M into NEOS as capital: its earlier €500K participative loan converted to equity plus €500K in new capital. The date and close of that second deal could not be confirmed, so it is left out here.